NO991481L - Nye heteroaryloksyetylaminer, fremgangsmÕte for fremstilling av, anvendelse som medisin og farmas°ytiske blandinger inneholdende disse - Google Patents
Nye heteroaryloksyetylaminer, fremgangsmÕte for fremstilling av, anvendelse som medisin og farmas°ytiske blandinger inneholdende disseInfo
- Publication number
- NO991481L NO991481L NO991481A NO991481A NO991481L NO 991481 L NO991481 L NO 991481L NO 991481 A NO991481 A NO 991481A NO 991481 A NO991481 A NO 991481A NO 991481 L NO991481 L NO 991481L
- Authority
- NO
- Norway
- Prior art keywords
- heteroaryloxyethylamines
- medicine
- preparation
- new
- pharmaceutical compositions
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/24—Oxygen atoms attached in position 8
- C07D215/26—Alcohols; Ethers thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/24—Oxygen atoms attached in position 8
- C07D215/26—Alcohols; Ethers thereof
- C07D215/28—Alcohols; Ethers thereof with halogen atoms or nitro radicals in positions 5, 6 or 7
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Psychiatry (AREA)
- Cardiology (AREA)
- Pain & Pain Management (AREA)
- Heart & Thoracic Surgery (AREA)
- Anesthesiology (AREA)
- Hospice & Palliative Care (AREA)
- Otolaryngology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9611798A FR2753968B1 (fr) | 1996-09-27 | 1996-09-27 | Nouvelles heteroaryloxyethylamines, leur procede de preparation, leur application comme medicaments et les compositions pharmaceutiques les renfermant |
PCT/FR1997/001691 WO1998013349A2 (fr) | 1996-09-27 | 1997-09-26 | Heteroaryloxyethylamines en tant que ligands 5-ht¿1a? |
Publications (3)
Publication Number | Publication Date |
---|---|
NO991481D0 NO991481D0 (no) | 1999-03-26 |
NO991481L true NO991481L (no) | 1999-03-26 |
NO311935B1 NO311935B1 (no) | 2002-02-18 |
Family
ID=9496126
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO19991481A NO311935B1 (no) | 1996-09-27 | 1999-03-26 | Nye heteroaryloksyetylaminer, anvendelse, fremgangsmåte for fremstilling derav og farmasöytiske preparater inneholdende dem |
Country Status (21)
Country | Link |
---|---|
US (1) | US6063784A (no) |
EP (1) | EP0929525B1 (no) |
JP (1) | JP2001503393A (no) |
AR (1) | AR008486A1 (no) |
AT (1) | ATE223380T1 (no) |
AU (1) | AU731459B2 (no) |
BR (1) | BR9711560A (no) |
CA (1) | CA2267247C (no) |
DE (1) | DE69715223T2 (no) |
DK (1) | DK0929525T3 (no) |
ES (1) | ES2182120T3 (no) |
FR (1) | FR2753968B1 (no) |
HU (1) | HUP0001189A3 (no) |
IL (1) | IL128917A (no) |
MY (1) | MY118992A (no) |
NO (1) | NO311935B1 (no) |
NZ (1) | NZ334623A (no) |
PL (1) | PL190221B1 (no) |
RU (1) | RU2176639C2 (no) |
TW (1) | TW425390B (no) |
WO (1) | WO1998013349A2 (no) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4507398B2 (ja) * | 1999-12-06 | 2010-07-21 | 宇部興産株式会社 | 3−ハロメチルオキセタン化合物の合成方法 |
US20040147581A1 (en) * | 2002-11-18 | 2004-07-29 | Pharmacia Corporation | Method of using a Cox-2 inhibitor and a 5-HT1A receptor modulator as a combination therapy |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK203990D0 (da) * | 1990-08-24 | 1990-08-24 | Novo Nordisk As | Piperazinylderivater |
MX9201991A (es) * | 1991-05-02 | 1992-11-01 | Jonh Wyeth & Brother Limited | Derivados de piperazina y procedimiento para su preparacion. |
US5240800A (en) * | 1991-07-29 | 1993-08-31 | Eastman Kodak Company | Near-infrared radiation sensitive photoelectrographic master and imaging method |
GB9507288D0 (en) * | 1995-04-07 | 1995-05-31 | Sod Conseils Rech Applic | Phenoxyethylamine derivatives with high affinity for 5-HT1A receptors |
-
1996
- 1996-09-27 FR FR9611798A patent/FR2753968B1/fr not_active Expired - Fee Related
-
1997
- 1997-09-24 AR ARP970104385A patent/AR008486A1/es unknown
- 1997-09-25 MY MYPI97004469A patent/MY118992A/en unknown
- 1997-09-26 IL IL12891797A patent/IL128917A/xx not_active IP Right Cessation
- 1997-09-26 US US09/254,787 patent/US6063784A/en not_active Expired - Fee Related
- 1997-09-26 JP JP51535198A patent/JP2001503393A/ja not_active Withdrawn
- 1997-09-26 CA CA002267247A patent/CA2267247C/fr not_active Expired - Fee Related
- 1997-09-26 NZ NZ334623A patent/NZ334623A/en unknown
- 1997-09-26 DK DK97943000T patent/DK0929525T3/da active
- 1997-09-26 ES ES97943000T patent/ES2182120T3/es not_active Expired - Lifetime
- 1997-09-26 DE DE69715223T patent/DE69715223T2/de not_active Expired - Lifetime
- 1997-09-26 HU HU0001189A patent/HUP0001189A3/hu unknown
- 1997-09-26 EP EP97943000A patent/EP0929525B1/fr not_active Expired - Lifetime
- 1997-09-26 RU RU99108674/04A patent/RU2176639C2/ru not_active IP Right Cessation
- 1997-09-26 TW TW086114116A patent/TW425390B/zh not_active IP Right Cessation
- 1997-09-26 AT AT97943000T patent/ATE223380T1/de not_active IP Right Cessation
- 1997-09-26 BR BR9711560A patent/BR9711560A/pt active Search and Examination
- 1997-09-26 PL PL97332480A patent/PL190221B1/pl not_active IP Right Cessation
- 1997-09-26 AU AU44637/97A patent/AU731459B2/en not_active Ceased
- 1997-09-26 WO PCT/FR1997/001691 patent/WO1998013349A2/fr active IP Right Grant
-
1999
- 1999-03-26 NO NO19991481A patent/NO311935B1/no unknown
Also Published As
Publication number | Publication date |
---|---|
PL190221B1 (pl) | 2005-11-30 |
US6063784A (en) | 2000-05-16 |
JP2001503393A (ja) | 2001-03-13 |
HUP0001189A2 (hu) | 2000-10-28 |
DE69715223D1 (de) | 2002-10-10 |
FR2753968A1 (fr) | 1998-04-03 |
ATE223380T1 (de) | 2002-09-15 |
IL128917A (en) | 2003-10-31 |
WO1998013349A2 (fr) | 1998-04-02 |
ES2182120T3 (es) | 2003-03-01 |
NO991481D0 (no) | 1999-03-26 |
HUP0001189A3 (en) | 2001-12-28 |
FR2753968B1 (fr) | 1998-11-27 |
DE69715223T2 (de) | 2003-04-30 |
CA2267247C (fr) | 2009-05-05 |
DK0929525T3 (da) | 2002-12-02 |
RU2176639C2 (ru) | 2001-12-10 |
AU4463797A (en) | 1998-04-17 |
CA2267247A1 (fr) | 1998-04-02 |
AR008486A1 (es) | 2000-01-19 |
MY118992A (en) | 2005-02-28 |
NZ334623A (en) | 1999-09-29 |
IL128917A0 (en) | 2000-02-17 |
TW425390B (en) | 2001-03-11 |
NO311935B1 (no) | 2002-02-18 |
WO1998013349A3 (fr) | 1998-11-05 |
PL332480A1 (en) | 1999-09-13 |
BR9711560A (pt) | 1999-08-24 |
AU731459B2 (en) | 2001-03-29 |
EP0929525A2 (fr) | 1999-07-21 |
EP0929525B1 (fr) | 2002-09-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK0885204T3 (da) | Nye arylglycinamidderivater, fremgangsmåde til fremstilling deraf og farmaceutiske præparater indeholdende disse forbindelser | |
NO964700D0 (no) | Nye aminosyrederivater, fremgangsmåte til deres fremstilling og farmasöytiske blandinger som inneholder disse forbindelser | |
NO975987D0 (no) | 4-Fenylaminotiazol-derivater, fremgangsmåte for fremstilling av disse og farmasöytiske blandinger inneholdende nevnte derivater | |
HUP0300894A3 (en) | Substituted beta-carbolines, process for their preparation, pharmaceutical compositions containing them and their use | |
NO973922L (no) | Nye taxoider, deres fremstilling og farmasöytiske preparater inneholdende forbindelsene | |
NO974685L (no) | Acetamidderivater, fremgangsmåte for fremstilling av disse, og farmasöytisk preparat inneholdende disse | |
HUP9900974A3 (en) | Heterocycle-condensed morphinoid derivatives, process for the preparation thereof, their use and pharmaceutical compositions containing them | |
DK1156049T3 (da) | Substituerede heterocykliske forbindelser, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger indeholdende disse | |
HUP0001508A3 (en) | 4-arylmethylene-2-imino-2,3-dihydrothiazole derivatives, their use, process for the preparation thereof and pharmaceutical compositions containing them | |
NO994620L (no) | Nye 2-(iminometyl)amino-fenyl-derivater, fremstilling, anvendelse som medisiner og farmasöytiske blandinger inneholdende disse | |
NO983955D0 (no) | Nye erytromycinderivater, metode for fremstilling av disse og anvendelse derav som legemidler | |
NO984290L (no) | Farmas°ytisk nyttige forbindelser | |
EE9900112A (et) | 2-tsüanoiminoimidasooli derivaadid, nende valmistamismeetod, kasutamine ja farmatseutilised kompositsioonid | |
NO308362B1 (no) | 10,13,15-trioksatrisyklo[9.2.1.19.6]pentadekanonderivater, fremgangsmÕte for deres fremstilling og legemidler som inneholder disse forbindelsene | |
NO992998D0 (no) | Nye analoger av camptotecin, anvendelse som medikamenter og farmas°ytiske blandinger som inneholder disse | |
EE9800264A (et) | Taksoidid, nende valmistamismeetod ja neid sisaldavad farmatseutilised kompositsioonid | |
NO955320D0 (no) | Substituerte 4-fenyltiazolderivater, fremgangsmåte for fremstilling derav og farmasöytiske blandinger som inneholder dem | |
FI960316A0 (fi) | Oksatiolaanit, menetelmä niiden valmistamiseksi ja niitä sisältävät farmaseuttiset koostumukset | |
NO20023249D0 (no) | Nye substituerte pyrazolo(4,3-e)ediazepiner, farmasöytiske preparater inneholdende disse, anvendelse som medisinske produkterog fremgangsmåter for fremstilling derav | |
NO20013878L (no) | (1-fenacy-3-fenyl-3-piperidylety)piperidinderivater, fremgangsmåte for fremstilling derav og farmasöytiske preparaterinneholdende de samme | |
NO991481L (no) | Nye heteroaryloksyetylaminer, fremgangsmÕte for fremstilling av, anvendelse som medisin og farmas°ytiske blandinger inneholdende disse | |
DK0806949T3 (da) | Ny farmaceutisk komposition, der indeholder trimebutin, og fremgangsmåde til fremstilling deraf | |
NO992298D0 (no) | Konformasjonsbegrensede LH-RH analoger, anvendelse derav og farmas°ytiske sammensetninger inneholdende disse | |
NO994908D0 (no) | Nye 4-halogenerte steroider, fremstillingsmetode og mellomprodukter, anvendelse som medisin, og farmasöytiske preparater inneholdende disse | |
NO991482L (no) | Nye fenoksyethylaminderivater, fremgangsmÕte for fremstilling, anvendelse som medisin og farmas°ytiske blandinger inneholdende disse |